OUR RESEARCH IS ABOUT YOU.

Join our brand new Psoriasis Registry! Learn more about it here.
Health Care Professionals: help our research by completing the KAP survey.
As a participant, share your story with us using our user-friendly online questionnaires.
As a health care provider, expand your ability to help your patients by partnering with us.
Learn about our pioneering research efforts that have been ongoing for the past 30+ years.

Patients

FORWARD partners with patient participants, who make a difference in rheumatic disease research by donating their time to completing a twice-yearly questionnaire about their rheumatic disease symptoms, treatment, and experience.

Join Us

Health Care Providers

FORWARD partners with health care providers from medical practices and academic centers to ensure that the patient voice is heard within research, a vital aspect necessary to improve the diagnosis, treatment, and prevention of rheumatic diseases.

Partner With Us

Researchers

FORWARD partners with academic and pharmaceutical researchers to improve our understanding of rheumatic diseases through data analysis, safety study management, and other research support and assistance.

Work With Us

Latest Publications

Information about recent research performed by FORWARD collaborators using FORWARD data.

RA Treatments Work, but Raise Infection Risk

The authors of this study, which was led by Kaleb Michaud, Ph.D., of the University of Nebraska Medical Center in Omaha, concluded that despite the efficacy of biologic DMARDs…

Relative Impact of Pain and Fatigue on Work Productivity in Patients with Rheumatoid Arthritis

To explore the relationship of pain and fatigue with daily activity and work productivity in rheumatoid arthritis (RA) patients from the baricitinib clinical trial, RA-BEAM.

Safety of abatacept compared with other biologic and conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis

To assess the risks of malignancies, infections and autoimmune diseases in patients with rheumatoid arthritis (RA) treated with abatacept…

Read latest publications

“We take a long look at the outcomes of these illnesses. This allows us to conduct observational studies that tell us, for example, how well a drug works under real-life circumstances, unlike clinical trials, which tell you only how well a drug can work under idealized circumstances.”

Dr. Fred Wolfe, Founder + Co-Director